B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge withMycobacterium tuberculosis
Top Cited Papers
- 1 June 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 178 (11) , 7222-7234
- https://doi.org/10.4049/jimmunol.178.11.7222
Abstract
Though much is known about the function of T lymphocytes in the adaptive immune response against Mycobacterium tuberculosis, comparably little is understood regarding the corresponding role of B lymphocytes. Indicating B cells as components of lymphoid neogenesis during pulmonary tuberculosis, we have identified ectopic germinal centers (GCs) in the lungs of infected mice. B cells in these pulmonary lymphoid aggregates express peanut agglutinin and GL7, two markers of GC B cells, as well as CXCR5, and migrate in response to the lymphoid-associated chemokine CXCL13 ex vivo. CXCL13 is negatively regulated by the presence of B cells, as its production is elevated in lungs of B cell-deficient (B cell−/−) mice. Upon aerosol with 100 CFU of M. tuberculosis Erdman, B cell−/− mice have exacerbated immunopathology corresponding with elevated pulmonary recruitment of neutrophils. Infected B cell−/− mice show increased production of IL-10 in the lungs, whereas IFN-γ, TNF-α, and IL-10R remain unchanged from wild type. B cell−/− mice have enhanced susceptibility to infection when aerogenically challenged with 300 CFU of M. tuberculosis corresponding with elevated bacterial burden in the lungs but not in the spleen or liver. Adoptive transfer of B cells complements the phenotypes of B cell−/− mice, confirming a role for B cells in both modulation of the host response and optimal containment of the tubercle bacillus. As components of ectopic GCs, moderators of inflammatory progression, and enhancers of local immunity against bacterial challenge, B cells may have a greater role in the host defense against M. tuberculosis than previously thought.Keywords
This publication has 55 references indexed in Scilit:
- Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapyClinical and Experimental Immunology, 2006
- Neutrophils and immunity: challenges and opportunitiesNature Reviews Immunology, 2006
- Interleukin‐10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosisImmunology, 2005
- Common interleukin 10 polymorphism associated with decreased risk of tuberculosisExperimental & Molecular Medicine, 2005
- Critical role of B cells in the development of T cell tolerance to aeroallergensInternational Immunology, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Neoteny in Lymphocytes: Rag1 and Rag2 Expression in Germinal Center B CellsScience, 1996
- Reactivation of Tuberculosis During Therapy with CorticosteroidsClinical Infectious Diseases, 1992
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- Peanut lectin binding properties of germinal centers of mouse lymphoid tissueNature, 1980